Knygos.lt klubas Knygos.lt nariams
61,94 €
-30%
Įprastai
88,49 €
Pfizer and the Challenges of the Global Pharmaceutical Industry
Pfizer and the Challenges of the Global Pharmaceutical Industry
Knygos.lt klubas Knygos.lt nariams
61,94 €
-30%
Įprastai
88,49 €
  • Išsiųsime per 12–18 d.d.
This Case Study defines the global pharmaceutical industry and its "boundaries", analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters' Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer's new strategy and examines what Pfizer did in the recent years to maintain their profitability.

Pfizer and the Challenges of the Global Pharmaceutical Industry (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

This Case Study defines the global pharmaceutical industry and its "boundaries", analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters' Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer's new strategy and examines what Pfizer did in the recent years to maintain their profitability.

Knygos.lt klubas
Knygos.lt nariams
61,94 €
-30%
Įprastai
88,49 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 0,88 Knygų Eurų!?
Išsiųsime per 12–18 d.d.
Įsigykite dovanų kuponą
Daugiau

This Case Study defines the global pharmaceutical industry and its "boundaries", analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters' Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer's new strategy and examines what Pfizer did in the recent years to maintain their profitability.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)